Exor H1 2025: Strategy still in waiting
26/09/25 -"Exor posts a modest NAV uptick, yet the lift owes more to share buybacks than portfolio strength. Liquidity is at record levels, but the path ahead is ambiguous. Luxury, tech, and healthcare are ..."
Pages
62
Language
English
Published on
26/09/25
You may also be interested by these reports :
26/09/25
Exor posts a modest NAV uptick, yet the lift owes more to share buybacks than portfolio strength. Liquidity is at record levels, but the path ahead ...
23/09/25
The Canal+ (BUY ; France) group was thrown into the LSE water following Vivendi’s (BUY ; France) split into four entities last December. That IPO had ...
22/09/25
The story is old, but the ambition is new. A 300-year-old family holdco now wants to dress up as a modern alternative asset manager. Eurazeo (BUY ; ...
17/09/25
Bolloré published mixed H1 25 results following the deconsolidation of Vivendi. The group continued to buy back its shares at a good pace, thus ...